Spots Global Cancer Trial Database for trust
Every month we try and update this database with for trust cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer | NCT03085992 | Rectal Cancer | FOLFOXIRI plus ... Chemoradiothera... | 18 Years - 75 Years | Azienda Ospedaliero, Universitaria Pisana | |
Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer | NCT03085992 | Rectal Cancer | FOLFOXIRI plus ... Chemoradiothera... | 18 Years - 75 Years | Azienda Ospedaliero, Universitaria Pisana | |
Randomized Trial of Trust in Online Videos About Prostate Cancer | NCT05886751 | Prostate Cancer | Black Doctor Sc... White Doctor Sc... Black Patient S... White Patient S... Black Doctor Cl... White Doctor Cl... Black Patient C... White Patient C... | 40 Years - | NYU Langone Health |